GenoVic will provide workflow management, variant interpretation, and a data repository that supports various analytics tools for clinicians across the state of Victoria.
Hospital will partner with several other institutions in this effort to support data-driven research into pediatric cancers and structural birth defects.
BIG offers free use of the warehouse to internal researchers and is reaching out to local companies in the Buffalo area working in genomics and other areas.
Omicia will use the proceeds to accelerate product development, expand sales and marketing, and extend variations of its flagship Opal Clinical platform for NGS data analysis.
